Zydus Lifesciences is targeting double-digit revenue growth for the fiscal year 2026, driven by robust performance in its ...

Indian drugmaker Zydus Lifesciences reported a higher adjusted fourth-quarter profit on Tuesday, driven by new drug launches in the U.S., its biggest market.

Zydus Lifesciences posted Q4 profit at Rs 1,170.90 crore, marginally lower than Rs 1182.30 crore recorded during the ...

The pharma companys Board has recommended a final dividend of Rs 11 per equity share of face value Rs 1 each, representing a ...

Zydus Lifesciences Limited announced a notable 19% increase in revenue for FY25, with net profits rising to Rs. 47,451 mn.

Results: Net profit for the quarter fell 1% from the year-ago period to ₹1,171 crore. The company reported a one-time loss of ...

The consolidated net profit of Zydus Lifesciences Ltd for the fourth quarter of financial year 2025 dropped marginally to ...

Zydus Lifesciences Limited reported a significant 19% increase in revenue for FY25, reaching Rs. 2,32,415 million. The ...

Result: Final dividend of Rs 11 per share announced, highest payout in over a decade The pharmaceutical major posted ...

This came after Zydus Lifesciences presented the proposal for a grant of permission to manufacture and market Aprepitant ...

Zydus Lifesciences, Fortis Healthcare, and Torrent Pharma will be among 146 companies to post earnings reports for the ...

Zydus Wellness Ltd (BOM:531335) reports robust quarterly performance with significant growth in personal care and food segments, while addressing market challenges and future strategies.